Style | Citing Format |
---|---|
MLA | Varshosaz J, Davoudi MA, Rasoulamini S. "Docetaxel-Loaded Nanostructured Lipid Carriers Functionalized With Trastuzumab (Herceptin) for Her2-Positive Breast Cancer Cells." Journal of Liposome Research, vol. 28, no. 4, 2018, pp. 285-295. |
APA | Varshosaz J, Davoudi MA, Rasoulamini S (2018). Docetaxel-Loaded Nanostructured Lipid Carriers Functionalized With Trastuzumab (Herceptin) for Her2-Positive Breast Cancer Cells. Journal of Liposome Research, 28(4), 285-295. |
Chicago | Varshosaz J, Davoudi MA, Rasoulamini S. "Docetaxel-Loaded Nanostructured Lipid Carriers Functionalized With Trastuzumab (Herceptin) for Her2-Positive Breast Cancer Cells." Journal of Liposome Research 28, no. 4 (2018): 285-295. |
Harvard | Varshosaz J, Davoudi MA, Rasoulamini S (2018) 'Docetaxel-Loaded Nanostructured Lipid Carriers Functionalized With Trastuzumab (Herceptin) for Her2-Positive Breast Cancer Cells', Journal of Liposome Research, 28(4), pp. 285-295. |
Vancouver | Varshosaz J, Davoudi MA, Rasoulamini S. Docetaxel-Loaded Nanostructured Lipid Carriers Functionalized With Trastuzumab (Herceptin) for Her2-Positive Breast Cancer Cells. Journal of Liposome Research. 2018;28(4):285-295. |
BibTex | @article{ author = {Varshosaz J and Davoudi MA and Rasoulamini S}, title = {Docetaxel-Loaded Nanostructured Lipid Carriers Functionalized With Trastuzumab (Herceptin) for Her2-Positive Breast Cancer Cells}, journal = {Journal of Liposome Research}, volume = {28}, number = {4}, pages = {285-295}, year = {2018} } |
RIS | TY - JOUR AU - Varshosaz J AU - Davoudi MA AU - Rasoulamini S TI - Docetaxel-Loaded Nanostructured Lipid Carriers Functionalized With Trastuzumab (Herceptin) for Her2-Positive Breast Cancer Cells JO - Journal of Liposome Research VL - 28 IS - 4 SP - 285 EP - 295 PY - 2018 ER - |